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While the world’s attention is riveted on the search
for a COVID-19 vaccine, we must not lose sight of the
pandemic’s impact on the prevention of other vaccinepreventable diseases (VPD). The reduction in morbidity and mortality from infectious disease is truly one of
public health’s greatest accomplishments.[1] Advances
in molecular biology have expanded the pool of vaccine platforms and worldwide research efforts towards
a COVID-19 vaccine have already produced multiple
vaccine candidates leading to several ongoing clinical
trials.[2] In the meantime, other pathogens have not
vanished as the world’s attention is diverted elsewhere.
The risk of resurgent COVID-19 through summer and
into the fall and winter season remains high, in the face
of economic and political pressures to open up nations
under virtual lockdown. It is certain that influenza will
reappear in the Northern Hemisphere by the end of
2020. Questions to be asked prospectively include: Will
there be enough influenza vaccine available and will
the means to deliver the vaccine exist when influenza
season returns? The World Health Organization published its recommendations for the composition of the
2020-21 influenza vaccine on February 28, 2020.[3] Will
production of adequate amounts of influenza vaccine
be possible as multiple companies focus on COVID-19
vaccine? Will the healthcare system be ready to vaccinate for influenza if a surge of new COVID-19 cases occurs at the same time? Since the clinical presentations
of COVID-19 and influenza are similar, prevention of
influenza is key in reducing diagnostic confusion in the
upcoming influenza season. Some evidence from Japan
suggests that both infections can coexist, providing additional diagnostic and therapeutic confusion.[4]
Hungerford and Cunliffe note that the pandemic will
impact VPD in several ways.[5] Whereas increased
hand hygiene, social distancing, and masking may reduce VPD, a negative and more significant impact may
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be on interruption of vaccination schedules in both
children and adults. In the United States, children
are already missing doses of vaccines due to the lockdown.[6] The result of missed doses could well be epidemics of measles and diphtheria if the missed doses
are not caught up quickly. This impact could occur
both domestically and internationally. Additionally,
programs to eradicate diseases such as polio will be
at risk in nations that already have weak public health
programs. As Hungerford and Cunliffe point out, governments and health agencies must monitor other VPD
and respond quickly as new outbreaks of those diseases
arise.
Finally, evidence is mounting on social media that antivaccination groups are actively fighting a proposed
COVID-19 vaccine.[7] The term vaccine hesitancy has
been used in an effort to lower tensions between pro
and anti-vaccine groups [8]; regardless of the term
used, failure to deploy vaccines on schedule remains
a significant impediment to public health and will only
increase morbidity and mortality from infectious disease. Rejection of an effective COVID-19 vaccine by
vaccine hesitant individuals will slow the world’s ability to emerge from this pandemic and will amplify
social and economic harm far beyond what has already occurred. Clinical medicine and public health
communities must be prepared to deal with the antivaccination threat.
As this is being written, we are at the six-month mark of
this pandemic. While a laser focus is appropriately on
development and testing of an effective COVID-19 vaccine, we must not forget about the threat of other VPD.
Vaccines are said to save lives but the act of vaccination
is a crucial step for eradication of infectious disease. An
effective vaccine in a vial is of little use until it is administered to a susceptible human.
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